Diphtheria and tetanus toxoids and acellular pertussis vaccine licensed for use
On Aug. 21, 1992, the Food and Drug Administration (FDA) approved licensure of a second DTaP product, prepared…
On Aug. 21, 1992, the Food and Drug Administration (FDA) approved licensure of a second DTaP product, prepared…
In 1986, the National Childhood Vaccine Injury Act was enacted by Congress. The Department of Health and Human…
On Apr. 6, 1977, the Department of Health, Education, and Welfare (now Department of Health and Human Services)…
In 1975, The World Health Assembly passed a resolution to create the Expanded Programme on Immunization (EPI) to…
In 1963, the U.S. Congress established the Immunization Grant Program; polio incidence plummeted to only 396 reported cases…
In 1953, tetanus and diphtheria toxoids (adult formulation) were first licensed in the U.S., after the concentration of…
On May 4, 1949, the diphtheria and tetanus toxoids and pertussis (DTP) vaccine was licensed. A greater than…
In 1947, a cmbination diphtheria and tetanus toxoids for pediatric use was first licensed in the U.S.
In 1941, Connaught Laboratories at the University of Toronto developed the first combined vaccines for diphtheria, pertussis, and…
In 1926, a statue of Balto, the heroic lead dog in the Iditarod Trail, used to transport diphtheria…
On Feb. 2, 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made…
In 1923, diphtheria toxoid was licensed; prepared from the inactivated bacterial toxin that has lost its toxicity but…
In 1914, the tetanus toxoid was introduced following the development of an effective therapeutic serum against tetanus by…
In 1905, Dr. Milton J. Rosenau conducted research resulting in the establishment of the official unit for the…
In 1901, diphtheria patients were routinely treated with antitoxin derived from the blood serum of horses. After 13…
In 1901, the first Nobel Prize for Physiology and Medicine was awarded to Emil von Behring for his…
In 1895, the H. K. Mulford Company, founded in Philadelphia, became the first commercial producer of diphtheria antitoxin…
In 1895, Joseph J. Kinyoun launched production of diphtheria antitoxin at the Hygienic Laboratory, one of the first…
In 1894, Kitasato Shibasaburo isolated the causative bacillus from buboes, later named Yersinia pestis, while he researched the…
In 1894, Alexandre Yersin, a member of the French Colonial Health Service in Hong Kong isolated from buboes…
In 1893, city and state public health departments began mass production of diphtheria antitoxin, following its introduction in…
In 1888, the diphtheria toxin was developed by Emile Roux at the Pasteur Institute. Passive serum therapies were…
In 1884, German scientist Friedrich Loffler isolated the diphtheria bacillus from patient’s throats.